(Press-News.org) Brussels, 8 November 2023 – New international research on the economic burden of urinary incontinence reveals that the cost of continence care will reach an estimated €69.1 billion in 2023. These costs include the impact of incontinence on individuals’ health, the costs of medical consultations and products such as continence pads, incontinence-related absenteeism at work, nursing home admissions, and the environmental impact of incontinence care. If no action is taken to support continence health, the economic burden could rise by 25% in 2030, to €86.7 billion. This economic burden becomes considerably higher when including caregiver costs.
Some 55-60 million Europeans suffer from problems with continence health (the ability to control the bladder and bowel). However, the health, economic and environmental burden attributed to urinary incontinence (UI) is largely unknown. The European Association of Urology together with 22 stakeholders have initiated a campaign, Urge to Act, that aims to achieve substantial change in policies relating to incontinence across Europe. This campaign will be kicked off on 8 November in Brussels at the first European Continence Health Summit.
At the Summit, a socio-economic report, the first of its kind, presents the burden of UI in the European Union countries (EU) in terms of the prevalence, healthcare costs and the environmental impact from 2023 to 2030. The report demonstrates that across all EU countries, the estimated economic burden of UI was €69.1 billion in 2023. The economic burden for females was four times higher than males, and the economic burden increases by 16% when accounting for the informal support provided by caregivers. Concerning waste disposal of continence pads, the cost of incinerating (burning the pads) was marginally lower than recycling. However, the carbon footprint of recycling is significantly lower.
The economic analysis presented in this report estimates the economic burden of UI could increase by 25% if no action is taken, to €86.7 billion in 2030. Without better awareness, prevention, treatment and resource-wise use of continence technologies in cases when this often chronic condition cannot be cured, the economic burden will most likely increase.
To present solutions, the manifesto for policy reform on transforming EU Continence Health is launched in parallel. The manifesto, endorsed by 23 organisations, calls for concrete policy changes to face the challenges posed by the report and makes 10 high-level recommendations to European and national policymakers to recognise the importance of patient-centred continence care and to promote a holistic understanding of the intricate links between continence health and healthy ageing, women’s health, as well as disease areas like cancer, mental health, neurological problems and several other comorbidities such as obesity. This will require increased funding for continence health research.
Professor Philip Van Kerrebroeck, co-chairman of the Policy Office of the European Association of Urology and leading expert in the field of incontinence, says: “Continence problems are felt across gender, age, and socio-economic backgrounds, and can result in a serious negative impact on individuals’ quality of life. Physical, psychosocial and economic consequences for patients and their carers are a barrier to full participation in society. Optimal continence health should be a reality for everyone.”
Since the risk of continence problems often correlates with conditions that develop or intensify as people age, it is predicted that these problems will increase, as the European population is ageing at a rapid pace. Health professionals and informal caregivers are making every effort within the existing constraints of different health systems. However, current systems are not yet fully adapted to support continence care. Policies and laws in both EU Member States and non-member European countries tend to neglect continence care despite its prevalence, serious nature, and availability of solutions.
Van Kerrebroeck: “It is time to take action and transform this neglected issue to address the continence health challenge Europe is facing. In our Urge to Act campaign we would like to make policymakers aware that there are many ways to improve continence health, through increased prevention, better care, access to supportive interventions including treatment, and more inclusive environments. Much more should be done to reduce the direct expenses, the burden on patients, their carers, and on society.”
END
The annual economic burden of urinary incontinence could reach €87 billion in 2030 if no action is taken
First Continence Health Summit in Brussels gives stark warning on costs related to continence care and presents a manifesto for policy reform
2023-11-08
ELSE PRESS RELEASES FROM THIS DATE:
Researchers say AI model accurately identifies, predicts joint damage in hand X-rays
2023-11-07
ATLANTA — New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that a deep learning system could accurately identify and predict joint space narrowing and erosions in hand radiographs of patients with rheumatoid arthritis (RA) (Abstract #0745).
Radiographs are the most commonly used imaging technique for detecting and monitoring RA in the hand. Radiologists frequently use the well-validated Sharp/van der Heidje (SvH) method to evaluate joint space ...
Study finds acute calcium pyrophosphate deposition arthritis doubles fracture risk
2023-11-07
ATLANTA - Researchers will present the first-ever study of fractures and calcium pyrophosphate deposition disease at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting. They report a doubled risk of fractures in patients with acute calcium pyrophosphate crystal arthritis compared to those without the disease (Abstract #0235).
Calcium pyrophosphate deposition (CPPD) disease occurs when calcium pyrophosphate (CPP) crystals form near cartilage cells, and sometimes leads to joint inflammation, pain, and swelling. It has often been called pseudogout because ...
Education key to curbing antimicrobial resistance in cats
2023-11-07
ITHACA, N.Y. -- Better education for cat owners, more communication from veterinarians, increased drug choices and cheaper, rapid diagnostic tools can help improve antimicrobial use in cats, which has important implications for rising antimicrobial resistance in animals and humans, according to two new papers by Cornell researchers.
Antimicrobial resistance threatens up to 10 million human lives a year and may cost the global economy trillions of dollars, with resistant pathogens moving easily between humans and animals, according to the papers’ authors.
In one paper, “Divergent Veterinarian and Cat ...
New compound shows early promise for treatment of Lou Gehrig’s disease in preclinical models
2023-11-07
In science, a simple but thorough observation can kick-start the most surprising findings. Researchers at the Hollings Cancer Center at the Medical University of South Carolina noticed that mice lacking a protein of interest in cancer research were showing visible signs of abnormal motor functions as they aged, including loss of coordination and strength. The team showed that that lack of this protein resulted in the accumulation of damaged mitochondria that affected motor function. Treating these mice with a drug that triggered the destruction of damaged mitochondria restored their motor ...
Diverse task force develops new quality measures to improve lupus care by 2030
2023-11-07
ATLANTA — Leaders of a project to develop and implement equitable new quality measures for lupus care by the end of the decade will present their work at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting (Abstract #1899).
Systemic lupus erythematosus (SLE, lupus) is an autoimmune disease marked by adaptive immune system activation, formation of autoantibodies, and systemic inflammation affecting organ systems throughout the body. Lupus disproportionately affects women and people of color, who are more likely to have severe ...
Study finds low anti-Ro titers are not associated with fetal heart block
2023-11-07
ATLANTA - New research from an ongoing study that will be presented at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that pregnant women with very low titers of anti-Ro antibodies are at minimal to no risk of fetal atrioventricular (AV) block, a serious disorder affecting the heart’s electrical system.
After birth, fetal AV block requires lifelong pacemaker treatment or cardiac transplantation and may be fatal. However, pregnant patients with higher titer antibodies seem to be at greatest risk at risk ...
Study finds hydroxychloroquine lowers risk of nonalcoholic fatty liver disease in rheumatoid arthritis patients
2023-11-07
ATLANTA - New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that treating rheumatoid arthritis with hydroxychloroquine (HCQ) reduced the risk of nonalcoholic fatty liver disease, especially in women and men who are 50 years old and younger (Abstract #0396).
Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory disease marked by chronic joint inflammation leading to joint damage and loss of function. It can also affect tissues and organs outside the joints, including (but not limited to) the eyes, ...
Study shows saliva gland abnormalities in Sjögren's worsens over time
2023-11-07
ATLANTA - New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that ultrasound-detected salivary gland abnormalities in primary Sjögren's become more severe over time and that the slow-to-progress disease likely starts long before it is first detected (Abstract #1371).
Sjögren's disease also known as Primary Sjögren’s syndrome, is a systemic autoimmune disorder. It is marked by inflammation of the lacrimal and salivary glands, leading to chronic dry eyes and mouth. Fatigue is common, ...
Study finds positive antiphospholipid antibodies raises cardiovascular disease risk in patients with systemic lupus erythematosus
2023-11-07
ATLANTA — New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, describes a link between positive antiphospholipid antibodies and an increased risk of future cardiovascular disease in patients with systemic lupus erythematosus (SLE) (Abstract #0552).
Antiphospholipid antibodies (aPLs) are autoantibodies directed against phospholipid-binding proteins. In antiphospholipid syndrome, they are associated with heart attack, stroke, and pulmonary embolism, and with miscarriage and stillbirth during pregnancy.
People with SLE also have a greatly increased risk ...
Study finds JAK inhibitors and tocilizumab effective in VEXAS syndrome
2023-11-07
ATLANTA - New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, found that JAK inhibitors (JAKi) and tocilizumab elicited better response rates in VEXAS syndrome compared to other targeted therapies (Abstract #L03).
VEXAS syndrome is a rare and often fatal autoimmune condition caused by a mutation in the UBA1 gene. It is marked by widespread inflammation leading to a range of symptoms that affect the skin, lungs, blood vessels and joints. The name is an acronym for disease characteristics: vacuoles in bone marrow, E1 enzyme (the enzyme encoded by the UBA1 gene), ...
LAST 30 PRESS RELEASES:
Effectiveness of exercise to ease osteoarthritis symptoms likely minimal and transient
Cost of copper must rise double to meet basic copper needs
A gel for wounds that won’t heal
Iron, carbon, and the art of toxic cleanup
Organic soil amendments work together to help sandy soils hold water longer, study finds
Hidden carbon in mangrove soils may play a larger role in climate regulation than previously thought
Weight-loss wonder pills prompt scrutiny of key ingredient
Nonprofit leader Diane Dodge to receive 2026 Penn Nursing Renfield Foundation Award for Global Women’s Health
Maternal smoking during pregnancy may be linked to higher blood pressure in children, NIH study finds
New Lund model aims to shorten the path to life-saving cell and gene therapies
Researchers create ultra-stretchable, liquid-repellent materials via laser ablation
Combining AI with OCT shows potential for detecting lipid-rich plaques in coronary arteries
SeaCast revolutionizes Mediterranean Sea forecasting with AI-powered speed and accuracy
JMIR Publications’ JMIR Bioinformatics and Biotechnology invites submissions on Bridging Data, AI, and Innovation to Transform Health
Honey bees navigate more precisely than previously thought
Air pollution may directly contribute to Alzheimer’s disease
Study finds early imaging after pediatric UTIs may do more harm than good
UC San Diego Health joins national research for maternal-fetal care
New biomarker predicts chemotherapy response in triple-negative breast cancer
Treatment algorithms featured in Brain Trauma Foundation’s update of guidelines for care of patients with penetrating traumatic brain injury
Over 40% of musicians experience tinnitus; hearing loss and hyperacusis also significantly elevated
Artificial intelligence predicts colorectal cancer risk in ulcerative colitis patients
Mayo Clinic installs first magnetic nanoparticle hyperthermia system for cancer research in the US
Calibr-Skaggs and Kainomyx launch collaboration to pioneer novel malaria treatments
JAX-NYSCF Collaborative and GSK announce collaboration to advance translational models for neurodegenerative disease research
Classifying pediatric brain tumors by liquid biopsy using artificial intelligence
Insilico Medicine initiates AI driven collaboration with leading global cancer center to identify novel targets for gastroesophageal cancers
Immunotherapy plus chemotherapy before surgery shows promise for pancreatic cancer
A “smart fluid” you can reconfigure with temperature
New research suggests myopia is driven by how we use our eyes indoors
[Press-News.org] The annual economic burden of urinary incontinence could reach €87 billion in 2030 if no action is takenFirst Continence Health Summit in Brussels gives stark warning on costs related to continence care and presents a manifesto for policy reform

